Related references
Note: Only part of the references are listed.Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Energy status dictates PD-L1 protein abundance and anti-tumor to enable blockade
Xiaoming Dai et al.
MOLECULAR CELL (2021)
PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain
Maorong Wen et al.
NATURE COMMUNICATIONS (2021)
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR
Soma Ghosh et al.
CELL REPORTS (2021)
KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway
Wenwen Du et al.
CELL DEATH AND DIFFERENTIATION (2021)
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
Yang Gao et al.
NATURE CELL BIOLOGY (2020)
PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Junwei Hou et al.
NATURE CELL BIOLOGY (2020)
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?
Cinzia Solinas et al.
TRANSLATIONAL ONCOLOGY (2020)
Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways
Tingting Ren et al.
CELL DEATH & DISEASE (2019)
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Han Yao et al.
NATURE BIOMEDICAL ENGINEERING (2019)
PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer
Trine Vilsboll Larsen et al.
CANCER COMMUNICATIONS (2019)
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression
Kathleen M. Mahoney et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity
Huanbin Wang et al.
NATURE CHEMICAL BIOLOGY (2019)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
The intracellular signalosome of PD-L1 in cancer cells
David Escors et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra et al.
NATURE (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. P. Carbone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Maria Gato-Canas et al.
CELL REPORTS (2017)
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
Curtis A. Clark et al.
CANCER RESEARCH (2016)
Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis
Madison Black et al.
ONCOTARGET (2016)
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
Yanping Xiao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Regulation of Protein Degradation by O-GlcNAcylation: Crosstalk with Ubiquitination
Hai-Bin Ruan et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
Gerald W. Hart et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
Marguerite Ghiotto et al.
INTERNATIONAL IMMUNOLOGY (2010)
ANALYSIS OF qPCR DATA BY CONVERTING EXPONENTIALLY RELATED Ct VALUES INTO LINEARLY RELATED X0 VALUES
RUNE THOMSEN et al.
Journal of Bioinformatics and Computational Biology (2010)
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
Takeshi Azuma et al.
BLOOD (2008)
The B7 family of immune-regulatory ligands
M Collins et al.
GENOME BIOLOGY (2005)
Cloning and identification of two novel splice variants of human PD-L2
XH He et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2004)
B7-DC regulates asthmatic response by an IFN-γ-dependent mechanism
K Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2004)
Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals
G Yeo et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2004)
Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction
SD Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Share Paper
